Mehreen Arif

Mehreen Arif

Auto-generated profile, based on publicly available information

Mehreen Arif

Shifa College of Pharmaceutical Sciences, Shifa Tameer e Millat University, Islamabad, Pakistan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2025 in Journal of Pharmaceutical Policy and Practice
Verified
Journal Article
Open access
AHAli Hassan
Ali Hassan
NRNaeem Ur Rehman
Naeem Ur Rehman
SMSumeira Maqbool
Sumeira Maqbool
MAMehreen Arif
Mehreen Arif
Antibiotics are widely used medications among infectious disease patients; therefore, proper monitoring and assessment are critical for ensuring rational use. Antimicrobial stewardship addresses the rational and appropriate use of antibiotics, which reinforces overall health outcomes. Ongoing antimicrobial resistance scenarios are an alarming condition for healthcare, necessitating continued practice of such assessments. To evaluate the use of antibiotics in patients with infectious diseases, implement and evaluate clinical pharmacy interventions that adhere to antimicrobial stewardship protocols. A before and after study was designed to evaluate clinical pharmacy and antimicrobial stewardship interventions for infectious disease patients at a tertiary care hospital in Lahore. A Performa was designed for manual data collection. Study first identified the signal of error, implemented intervention and noted post-interventional followups. 102 infectious disease cases were analyzed in total and proposed 136 interventions. Physicians accepted 66% of the interventions (90) and rejected the remaining ones as unjustified. The most accepted intervention was the spectrum-based choice (n = 30), followed by de-escalation of dose (n = 17). Use of ceftriaxone was very high (54 Pt.), followed by vancomycin (30 Pt.). Antimicrobial stewardship programmes are critical for any institution's proper health care system. It ensures proper antibiotic outflow to patients, thereby improving their health status. The role of pharmacists in establishing an AMS in a hospital setting is a highly commendable activity that enhances healthcare collaboration and outcomes. Clinical pharmacists should implement such activities to improve patient care.

4 August 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
KMKausar Ali Mahsud
Kausar Ali Mahsud
MAMehreen Arif
Mehreen Arif
MAMuhammad Syed Anwar
Muhammad Syed Anwar
SASajjad Ahmad
Sajjad Ahmad
SRShafiq Ur Rehman
Shafiq Ur Rehman
NRNaeem Ur Rehman
Naeem Ur Rehman

8 December 2025 in ASIDE Case Reports
Verified
Journal Article
Open access
MRMuhammad Rahid
Muhammad Rahid
NRNaeem Ur Rehman
Naeem Ur Rehman
MAMehreen Arif
Mehreen Arif
Deficits in communication, social interaction, and behavior mark autism spectrum disorder (ASD). In low-resource settings, diagnostic delays and excessive early screening exposure complicate clinical profiles and access to therapy. We present a 7-year-old female from a rural community in Pakistan who presents with profound regression in speech, social interaction, and adaptive behavior. A child psychiatrist used DSM-5 criteria to diagnose ASD, which should be regarded as a working clinical impression. The child had no prior family history of neurodevelopmental disorders. Still, beginning in infancy, the patient had a history of extended unsupervised mobile screen exposure (3–5 hours/day of animated content). Symptoms included echolalia, idiosyncratic language, violence toward animals and peers without remorse, toileting difficulties, and emotional detachment. Carers reported fewer violent outbursts (from daily to 1-2/week) and better sleep (from 3-4 to 6-7 hours/night). Over the course of six months, risperidone (up to 1 mg/day) and carbamazepine (200 mg/day) partially improved aggression (from daily to 1-2 times/week) and sleep (from 3 to 7 hours/night), but social and language impairments remained. There were confounding variables, such as low socioeconomic position, and no standardized developmental assessments were conducted. This single case suggests that excessive early screen time may be associated with or modulate neurodevelopment. Due to the dearth of research and the absence of standardized ASD tests, it is not possible to conclude on screen time. This case illustrates gaps in ASD diagnosis and management and emphasizes the need for awareness campaigns, low-cost therapies, and culturally contextualized interventions.

8 October 2026 in Current Drug Targets
Verified
Journal Article
Closed access
AAAisha Altaf
Aisha Altaf
MAMehreen Arif
Mehreen Arif
WIWali Inam
Wali Inam
GAGhulam Abbas
Ghulam Abbas
WQWajahat Qazi
Wajahat Qazi
Introduction/Objective: BACE1 (Beta-Site Amyloid precursor protein-cleaving enzyme is a rate-limiting aspartic protease responsible for beginning Amyloid-β (Aβ) peptide synthesis, the major neurotoxic characteristic of Alzheimer's Disease (AD). Repurposing drugs with known safety profiles and Blood-Brain Barrier (BBB) permeability is a practical approach to treating AD. The current work combined in silico and in vivo approaches to investigate Sulfamethoxazole (SMZ) as a potential BACE1-interacting compound. Methods: Molecular docking of sulfamethoxazole to the BACE1 crystal structure (PDB: 1FKN) was done using AutoDock Vina. Female Sprague-Dawley rats (n = 6/group) received AlCl3 (500 mg/kg, i.g.) for 30 days to induce cognitive impairment, while SMZ (0.5, 1.0, and 1.5 mg/kg) was coadministered with AlCl3 for 30 days. On Days 31–36, locomotor activity assessments and the Morris Water Maze (MWM) were used to measure neurocognitive function. Results: Docking revealed prominent hydrogen-bond interactions between SMZ's sulfonamide oxygen atoms and the Tyr71, Asp228, and Thr72 residues, with the isoxazole ring occupying the hydrophilic S2 pocket of BACE1. Molecular docking analysis indicated a favorable interaction between SMZ and BACE1, suggesting BACE1 as a potential molecular target. In vivo, SMZ dosedependently reversed AlCl3-induced cognitive decline: reduced escape latency (F(1,27) = 117.0; p < 0.0001) and increased time spent in the platform quadrant (F(13.21; 6,6) = p < 0.05). Locomotor activity was unaffected (F(1.150; 3.24); p > 0.05), confirming the absence of CNS stimulation. Discussion: The findings provide preliminary computational and behavioral evidence supporting further investigation of SMZ in cognitive dysfunction. However, docking predictions do not establish direct BACE1 inhibition, and biochemical validation was not performed. Conclusion: SMZ attenuated AlCl3-induced cognitive impairment in rats and demonstrated a favorable predicted interaction with BACE1. Further studies are required to validate the proposed molecular mechanism and determine the therapeutic relevance of SMZ in cognitive dysfunction.